The American Society of Addiction Medicine revised the definition of addiction in 2019 as follows: “Addiction is a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual’s life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences. Prevention efforts and treatment approaches for addiction are generally as successful as those for other chronic diseases.” This training will focus on the disease of opioid use disorder (OUD) and the medications used in combination with behavioral treatment to manage this chronic disease and assist patients in achieving recovery and long-term sobriety.
- Review & define terminology and abbreviations commonly used in OUD treatment: MAT, MOUD, OAT, opioid agonist, partial opioid agonist, opioid antagonist, opiate vs opioid, detoxification vs maintenance.
- Explain the harm reduction model and its relevance in assessing the effectiveness of treatment.
- Describe how the 3 FDA-approved medications – methadone, buprenorphine, and naltrexone - work physiologically and practically from the perspective of the patient and the provider recommending these medications.
- Discuss the role of naloxone and its universal role for all patients with OUD.
- Explore the ways in which HIV medications are used as an adjunctive form of MAT.
- Provide factual responses to common myths to help reduce the stigma associated with OUD and the medications used in its treatment
- Empower learners to advocate for OUD medication with confidence and competence.